Ekso Bionics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $2,057 | $3,375 | $5,090 | $4,129 |
Gross Profit | 819 | 1,806 | 2,714 | 2,209 |
EBITDA | -3,975 | -3,440 | -2,956 | -1,586 |
EBIT | -4,352 | -2,963 | -3,354 | -1,993 |
Net Income | -2,709 | -2,891 | -3,413 | -2,072 |
Net Change In Cash | 2,057 | 3,375 | 5,090 | 4,129 |
Free Cash Flow | -3,444 | -1,965 | -1,454 | -2,285 |
Cash | 5,242 | 8,054 | 6,493 | 8,292 |
Basic Shares | 2,180 | 25,393 | 24,640 | 20,310 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $17,925 | $18,279 | $12,912 | $11,246 |
Gross Profit | 9,511 | 9,079 | 6,214 | 6,749 |
EBITDA | -9,453 | -13,198 | -14,037 | -9,090 |
EBIT | -11,061 | -14,896 | -14,924 | -9,651 |
Net Income | -11,330 | -15,198 | -15,080 | -9,764 |
Net Change In Cash | 17,925 | 18,279 | 12,912 | 11,246 |
Free Cash Flow | -9,883 | -12,211 | -14,882 | -11,215 |
Cash | 6,493 | 8,638 | 20,525 | 40,406 |
Basic Shares | 20,161 | 13,867 | 12,962 | 12,269 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.24 |
2025-03-31 | -$0.12 |
2024-12-31 | -$0.14 |
2024-09-30 | -$0.10 |
